PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0600260|obstructive pulmonary disease |
| Sentences | 14 |
| PubMedID- 22077976 | Cardiovascular disease is common in patients with chronic obstructive pulmonary disease (copd) but often remains unrecognized. |
| PubMedID- 25655487 | Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease. |
| PubMedID- 23237442 | [the place of beta-adrenoblockers in the treatment of cardiovascular disease in patients with chronic obstructive pulmonary disease]. |
| PubMedID- 24582881 | Has also been considered a risk factor for various isolated diseases, including chronic obstructive pulmonary disease (copd), different types of cancer, hemodynamic alterations, vascular disease, infectious diseases, among others. |
| PubMedID- 24837395 | Beta-blockers, especially selective beta1 -adrenoceptor antagonists, are often used to treat cardiovascular disease, even when complicated by chronic obstructive pulmonary disease. |
| PubMedID- PMC3485663 | Curkendall sm, deluise c, jones jk, lanes s, stang mr, goehring e jr, she d. cardiovascular disease in patients with chronic obstructive pulmonary disease, saskatchewan canada cardiovascular disease in copd patients. |
| PubMedID- 23272688 | Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (copd). |
| PubMedID- 25194870 | Chronic obstructive pulmonary disease is often associated with cardiovascular diseases, such as pulmonary hypertension, ischemic heart disease, arrhythmias or heart failure. |
| PubMedID- 23258468 | Introduction: cardiovascular diseases often coexist with chronic obstructive pulmonary disease (copd), and in some cases it is difficult to differentiate between cardiac and pulmonary cause of dyspnoea. |
| PubMedID- 20714372 | Background: the benefit harm profile of inhaled corticosteroids, and their effect on patient oriented outcomes and comorbid pneumonia, osteoporosis and cardiovascular disease in patients with chronic obstructive pulmonary disease remain uncertain. |
| PubMedID- 23534269 | [the effects of hypoxia on initiation and progression of cardiovascular disease in patients with chronic obstructive pulmonary disease]. |
| PubMedID- 23237325 | Background: reasons for the excess risk for cardiovascular disease among people with chronic obstructive pulmonary disease remain unclear. |
| PubMedID- 23786593 | Chronic obstructive pulmonary disease (copd) is associated with cardiovascular disease-related mortality. |
| PubMedID- 23839654 | Aims: recent studies have demonstrated that chronic obstructive pulmonary disease (copd) is associated with cardiovascular disease (cvd). |
Page: 1